Hikma Pharmaceutical reported 873M in Operating Expenses for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
AstraZeneca AZN:LN 7.09B 1.67B
Bayer BAYN:GR 13.14B 3.89B
Fresenius FRE:GR 8.22B 247M
Galapagos GLPG:NA 199.82M 24.86M
Genmab GEN:DC 1.18B 136M
GlaxoSmithKline GSK:LN 6.42B 692M
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.36B 27M
Hikma Pharmaceutical HIK:LN 873M 27M
Lonza Group LONN:SW 2.22B 1.07B
Merck MRK:GR 3.82B 233M
Orion ORNBV:FH 183.9M 9.8M
Recordati REC:IM 260.52M 565K